SCHEMBL4595969

SCHEMBL4595969

CN=CC=CC=NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10066350 0.82
SCHEMBL19019141 0.82
SCHEMBL20191642 0.82
SCHEMBL12820644 0.82
SCHEMBL13964121 0.82
SCHEMBL7992428 0.82
SCHEMBL11953507 0.82
SCHEMBL14067022 0.82
SCHEMBL13026946 0.79
SCHEMBL21191554 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174523-A1 FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION ALLERGAN, INC. (US) 2017-06-07 EP disclosed
EP-3137053-A1 FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION ALLERGAN, INC. (US) 2017-03-08 EP disclosed
WO-2016019180-A1 FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION ALLERGAN, INC. (US) 2016-02-04 WO disclosed
WO-2015168471-A1 FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION ALLERGAN, INC. (US) 2015-11-05 WO disclosed
EP-1871432-A2 BORATE-POLYOL MIXTURES AS A BUFFERING SYSTEM Advanced Medical Optics, Inc. (US) 2008-01-02 EP disclosed
EP-1850888-A1 Contact lens care composition Obwaller, Andreas (AT) 2007-11-07 EP disclosed
EP-1732617-A1 ALKYLAMINE AS AN ANTIMICROBIAL AGENT IN OPHTHALMIC COMPOSITIONS Advanced Medical Optics, Inc. (US) 2006-12-20 EP disclosed
EP-1733014-A1 CETYLPYRIDINIUM CHLORIDE AS AN ANTIMICROBIAL AGENT IN OPHTHALMIC COMPOSITIONS Advanced Medical Optics, Inc. (US) 2006-12-20 EP disclosed
WO-2006110482-A2 BORATE-POLYOL MIXTURES AS A BUFFERING SYSTEM ADVANCED MEDICAL OPTICS, INC. (US) 2006-10-19 WO disclosed
WO-2006089320-A1 Contact lens care composition OBWALLER ANDREAS (AT) 2006-08-31 WO disclosed
WO-2004058930-A1 CONTACT LENS CARE COMPOSITIONS, METHODS OF USE AND PREPARATION WHICH PROTECT OCULAR TISSUE MEMBRANE INTEGRITY ADVANCED MEDICAL OPTICS, INC. (US) 2004-07-15 WO disclosed
WO-2004045661-A1 MULTI PURPOSE CONTACT LENS CARE COMPOSITIONS INCLUDING PROPYLENE GLYCOL OR GLYCERIN ADVANCED MEDICAL OPTICS, INC. (US) 2004-06-03 WO disclosed
EP-1406647-A1 USE OF ANTIMICROBIAL PEPTIDES AS PRESERVATIVES IN OPHTHALMIC PREPARATIONS INCLUDING SOLUTIONS EMULSIONS AND SUSPENSIONS Allergan, Inc. (US) 2004-04-14 EP disclosed
EP-1383377-A1 COMPOSITIONS INCLUDING VITAMIN-BASED SURFACTANTS AND METHODS FOR USING SAME Allergan, Inc. (US) 2004-01-28 EP disclosed
WO-2003006046-A1 USE OF ANTIMICROBIAL PEPTIDES AS PRESERVATIVES IN OPHTHALMIC PREPARATIONS INCLUDING SOLUTIONS EMULSIONS AND SUSPENSIONS ALLERGAN, INC. (US) 2003-01-23 WO disclosed
WO-2002087326-A1 COMPOSITIONS INCLUDING VITAMIN-BASED SURFACTANTS AD METHODS FOR USING SAME ALLERGAN, INC. (US) 2002-11-07 WO disclosed
EP-1034005-A1 MULTI-PURPOSE CONTACT LENS CARE COMPOSITIONS Allergan Sales, Inc. (US) 2000-09-13 EP disclosed
EP-0983093-A1 COMPOSITIONS AND METHODS FOR ENHANCING CONTACT LENS WEARABILITY Vision Pharmaceuticals L.P. (US) 2000-03-08 EP disclosed
WO-1999026669-A1 MULTI-PURPOSE CONTACT LENS CARE COMPOSITIONS ALLERGAN SALES, INC. (US) 1999-06-03 WO disclosed
WO-1998050084-A1 COMPOSITIONS AND METHODS FOR ENHANCING CONTACT LENS WEARABILITY ALLERGAN SALES, INC. (US) 1998-11-12 WO disclosed